跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 177 条关于
“Helmholtz-Zentrum Dresden-Rossendorf”
全部
177
临床试验
57
药物
12
机构
61
资讯
47
去年
NCT/UCC Dresden Launches Phase 2 Trial of Personalized mRNA Vaccine for Pancreatic Cancer
2个月前
Two New Methods Break Down "Forever Chemicals" in Water
2个月前
Bacteria Convert Toxic Uranium into a Stable Compound, Opening New Paths for Environmental Remediation
去年
Taconic Biosciences Secures Exclusive CRISPR License from Helmholtz Munich to Enhance Animal Model Generation
上个月
Blood-Filtering Technique for Cholesterol Also Removes Forever Chemicals and Microplastics, Study Finds
7个月前
Eli Lilly Partners with Seamless Therapeutics in $1.1 Billion Gene Editing Deal for Hearing Loss
2年前
TherVacB Therapeutic Vaccine Begins First-in-Human Trial for Chronic Hepatitis B
14天前
AI-Designed Protein Vehicles Outperform Lipid Nanoparticles for RNA and CRISPR Delivery
去年
Repare Therapeutics' Gynecological Cancer Trial Shows Mixed Results, Beigene Inks $1.5B Deal for MAT2A Inhibitor
上个月
Neutrophil-Derived Il-4 Drives Spinal Cord Regeneration in Zebrafish, Study Finds
第 1 页，共 5 页
上一页
下一页
